Report overview
Hereditary cancer testing is a process of identifying an inherited gene mutation that increases the risk of cancer development. It mainly includes predictive genetic testing and clinical DNA sequencing, in predictive genetic testing, patient?s family history is analyzed for any inherited mutation from ancestry. In DNA sequencing, entire DNA or genome of an individual is analyzed. It is useful for testing many genetic mutations at a time.
This report contains market size and forecasts of Hereditary Cancer Testing in Global, including the following market information:
Global Hereditary Cancer Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hereditary Cancer Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
RNA Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hereditary Cancer Testing include Ambry Genetics (Konica Minota), Asper Biogene, Natera, Caris Life Sciences, BioReference Laboratories (GeneDx), LabSolutions, Progenity?Inc, ARUP Laboratories and Myriad, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hereditary Cancer Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hereditary Cancer Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hereditary Cancer Testing Market Segment Percentages, by Type, 2021 (%)
RNA Testing
DNA Testing
Global Hereditary Cancer Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hereditary Cancer Testing Market Segment Percentages, by Application, 2021 (%)
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers
Global Hereditary Cancer Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hereditary Cancer Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hereditary Cancer Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hereditary Cancer Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ambry Genetics (Konica Minota)
Asper Biogene
Natera
Caris Life Sciences
BioReference Laboratories (GeneDx)
LabSolutions
Progenity?Inc
ARUP Laboratories
Myriad
NeoGenomics
Blueprint Genetics
CellMax Life
Fulgent Genetics
Strand Life Sciences
Myogenes
LabCorp
Quest Diagnostics
Pathway Genomics
